Clinical Trials Logo

Clinical Trial Summary

This randomized, parallel controlled, single blind trial is designed to evaluate the efficacy and safety of hydromorphone versus morphine for perioperative analgesia in lung tumor ablation.


Clinical Trial Description

Although the consensus of relevant guidelines and clinical studies recommend the use of opioids for perioperative analgesia in pulmonary tumor ablation surgery, there is a lack of specific analgesic programs for clinical reference. In view of the advantages of clinical application of hydromorphone and the lack of evidence for its application in perioperative analgesia of pulmonary tumor ablation, this study aims to explore the efficacy and safety of hydromorphone in perioperative analgesia of pulmonary tumor ablation, and provide some reference and suggestions for perioperative analgesia of pulmonary tumor ablation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05848635
Study type Interventional
Source Qianfoshan Hospital
Contact Xin Ye, graduate
Phone 18906417755
Email yexintaian@aliyun.com
Status Not yet recruiting
Phase Phase 4
Start date May 1, 2023
Completion date May 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05073744 - Nalbuphine Versus Morphine for Perioperative Tumor Ablation Phase 4
Active, not recruiting NCT05270642 - Plan for Microwave Thermal Field N/A
Recruiting NCT03591627 - Left Atrial Thrombus on Transesophageal Echocardiography
Completed NCT04293198 - Evaluating the Performance of the KODEX-EPD CRyOballoon Occlusion Feature in Patients With Atrial Fibrillation
Terminated NCT01546168 - Deviating the Esophagus in Atrial Fibrillation Ablation N/A
Recruiting NCT05698576 - TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer N/A
Completed NCT05498779 - Ablation of Hepatocellular Carcinoma: a Nationwide Study
Enrolling by invitation NCT04893278 - Virtual Reality in Electrophysiology Laboratory (EP)
Not yet recruiting NCT01833286 - TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma Phase 3
Recruiting NCT01229306 - Repeat Ablation Procedure in Patients With Relapse of Atrial Fibrillation N/A
Completed NCT03844841 - The Deep Sedation for Ablation Study Phase 4
Recruiting NCT03249545 - Late Effect of Ablation on Premature Ventricular Complex Ablation N/A
Completed NCT01229033 - Ablating Atrial Tachycardias Occuring During Ablation of Complex Fractionated Electrograms in Persistent AF N/A
Recruiting NCT06134739 - Arterial Embolism After Catheter Ablation of Atrial Fibrillation. ATRIAL FIBRILLATION
Recruiting NCT06172699 - Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study
Recruiting NCT05257694 - Clinical Decision Biological Biomarker and Prognosis Prediction of Hepatocellular Carcinoma by Deep Learning
Recruiting NCT03871140 - Utility of Ultrasound Imaging for Diagnosis of Focal Liver Lesions: A Radiomics Analysis
Not yet recruiting NCT06231160 - Clinical Comparative Study of Systematic Therapy Combined With MWA and Systematic Therapy for Pancreatic Cancer
Completed NCT01896219 - CTNAV II : Multicentric Evaluation of IMACTIS-CT Navigation System N/A
Active, not recruiting NCT04046354 - Microwave vs. Radiofrequency Ablation for Benign Thyroid Nodules: A Multicenter Randomized Controlled Trial Study N/A